The Clinical and Molecular Characterization of Distinct Subtypes in Adult T Cell Acute Lymphoblastic Leukemia
Cancer Science · 2025
DOI: 10.1111/cas.70010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Heye Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
T‐cell acute lymphoblastic leukemia (T‐ALL) is a clonal proliferative malignant disease characterized by abnormal T‐cell development. The classification of T‐ALL primarily hinges on immunophenotype, encompassing early T‐cell precursor (ETP)‐ALL, near‐ETP‐ALL, and non‐ETP‐ALL. We summarized clinical information from 117 patients, with genetic data available for 77 patients and transcriptomic data available for 24 patients. An ETP‐like score model was established based on transcriptome, aiming to address the subjectivity in the current T‐ALL immunophenotype classification. The retrospective analysis indicated that ETP immunophenotype was not a prognostic factor for T‐ALL patients. Compared to non‐ETP‐ALL patients, ETP‐like patients including ETP‐ALL and near‐ETP‐ALL were more likely to carry MED12 gene mutations, which may predict a dismal outcome. Transcriptomic analysis suggested that T‐ALL patients with different immunophenotypes were in accordance with the T‐cell development trajectory, while ETP‐like patients exhibited characteristics of early T‐cell development. Finally, we established an ETP‐like score model and confirmed its efficiency across four independent cohorts, with sensitivity exceeding 80%. And T‐ALL patients with high ETP‐like score were associated with poor prognosis. In conclusion, our study elucidated the clinical and molecular features of distinct subtypes of T‐ALL patients, providing new valuable insights for T‐ALL classification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical…
- Tianjin Institutes of Health Science, Tianjin, China.
ORCID-Profile: Shaowei Qiu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
- Clinical Research Foundation of National Clinical Research Center for Blood Diseases
- Tianjin Municipal Science and Technology Commission Grant
Zitieren
APA
Yu, H., Liu, W., Zhang, J., Xie, L., Lai, A., Tian, Z., Tang, K., Xing, H., Wang, Y., Wei, H., Rao, Q., Gu, R., Wang, M., Wang, H., Wang, J., & Qiu, S. (2025). The Clinical and Molecular Characterization of Distinct Subtypes in Adult T Cell Acute Lymphoblastic Leukemia. Cancer Science. https://doi.org/10.1111/cas.70010
Vancouver
Yu H, Liu W, Zhang J, Xie L, Lai A, Tian Z, et al. The Clinical and Molecular Characterization of Distinct Subtypes in Adult T Cell Acute Lymphoblastic Leukemia. Cancer Science. 2025. doi:10.1111/cas.70010
BibTeX
@article{Yu2025,
author = {Yu, Heye and Liu, Wenbing and Zhang, Junping and Xie, Leling and Lai, Anli and Tian, Zheng and Tang, Kejing and Xing, Haiyan and Wang, Ying and Wei, Hui and Rao, Qing and Gu, Runxia and Wang, Min and Wang, Huijun and Wang, Jianxiang and Qiu, Shaowei},
title = {The Clinical and Molecular Characterization of Distinct Subtypes in Adult T Cell Acute Lymphoblastic Leukemia},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70010}
}
EUVIMED